Mosaic ImmunoEngineering (CPMV) Capital Expenditures (2011 - 2018)
Mosaic ImmunoEngineering (CPMV) posted quarterly Capital Expenditures of $1465.0 for Q1 2018, down 45.8% quarter-over-quarter from $2703.0 in Q3 2016.
Mosaic ImmunoEngineering (CPMV) Capital Expenditures (2011 - 2018) Analysis & Trends
Mosaic ImmunoEngineering's Capital Expenditures history runs 7 years deep, the most recent figure standing at $1465.0 for Q1 2018.
- In Q1 2018, Capital Expenditures changed N/A year-over-year to $1465.0; the TTM figure through May 2019 stood at $1465.0 (changed 0.0% YoY), while the FY2018 annual figure was $1465.0, down 45.8% from the prior year.
- Capital Expenditures for Q1 2018 stood at $1465.0, down from $2703.0 in the prior quarter.
- The five-year high for Capital Expenditures was $2703.0 in Q3 2016, with the low at $477.0 in Q2 2015.
- The 4-year median for Capital Expenditures is $702.0 (2014), against an average of $1177.4.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 251.02 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2018 | 1,465.00 |
| Feb 28, 2018 | 1,465.00 |
| Aug 31, 2016 | 2,703.00 |
| Aug 31, 2016 | 2,703.00 |
| May 31, 2015 | 477.00 |
| May 31, 2015 | 477.00 |
| Nov 30, 2014 | 540.00 |
| Nov 30, 2014 | 540.00 |
| Aug 31, 2014 | 702.00 |
| Aug 31, 2014 | 702.00 |
| Feb 28, 2013 | 928.00 |
| Feb 28, 2013 | 928.00 |
| Nov 30, 2012 | 701.00 |
| Nov 30, 2012 | 701.00 |
| Aug 31, 2012 | 539.00 |
| Aug 31, 2012 | 539.00 |
| Feb 29, 2012 | -2.55 Mn |
| Feb 29, 2012 | -2.55 Mn |
| Nov 30, 2011 | 2.55 Mn |
| Nov 30, 2011 | 2.55 Mn |